Vaccine, 1873-2518

Journal

More filtering options
  1. 2020
  2. Validation of the new Swedish vaccination register – Accuracy and completeness of register data

    Chrapkowska, C., Galanis, I., Kark, M., Lepp, T., Lindstrand, A., Adam Roth & Nilsson, A., 2020 May 22, In : Vaccine. 38, 25, p. 4104-4110 7 p.

    Research output: Contribution to journalArticle

  3. Confidence in the National Immunization Program among parents in Sweden 2016 – A cross-sectional survey

    Emma Byström, Lindstrand, A., Bergström, J., Kristian Riesbeck & Adam Roth, 2020 Feb 11, In : Vaccine.

    Research output: Contribution to journalArticle

  4. Cost-effectiveness of pneumococcal vaccination for elderly in Sweden

    Wolff, E., Storsaeter, J., Örtqvist, Å., Naucler, P., Larsson, S., Lepp, T. & Adam Roth, 2020, In : Vaccine.

    Research output: Contribution to journalArticle

  5. 2018
  6. Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour

    Wolff, E., Elfström, K. M., Haugen Cange, H., Larsson, S., Englund, H., Sparén, P. & Adam Roth, 2018 Aug 16, In : Vaccine. 36, 34, p. 5160-5165 6 p.

    Research output: Contribution to journalArticle

  7. Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data

    Vänskä, S., Anna Söderlund-Strand, Uhnoo, I., Lehtinen, M. & Dillner, J., 2018 Apr 30, In : Vaccine.

    Research output: Contribution to journalArticle

  8. Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs

    Dillner, J., Nygård, M., Munk, C., Hortlund, M., Hansen, B. T., Lagheden, C., Liaw, K. L. & Kjaer, S. K., 2018 Jan 1, In : Vaccine.

    Research output: Contribution to journalArticle

  9. Barriers to immunization among newcomers: A systematic review

    Wilson, L., Rubens-Augustson, T., Murphy, M., Jardine, C., Crowcroft, N., Hui, C. & Wilson, K., 2018, In : Vaccine. 36, 8, p. 1055-1062 12 p.

    Research output: Contribution to journalArticle

  10. 2017
  11. Vaccination against hepatitis B virus among people who inject drugs – A 20 year experience from a Swedish needle exchange program

    M. Alanko Blomé, P. Björkman, Flamholc, L., Jacobsson, H. & A. Widell, 2017 Jan 3, In : Vaccine. 35, 1, p. 84-90 7 p.

    Research output: Contribution to journalArticle

  12. 2016
  13. Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.

    Faust, H., Toft, L., Sehr, P., Müller, M., Bonde, J., Ola Forslund, Østergaard, L., Tolstrup, M. & Dillner, J., 2016, In : Vaccine. p. 1559 1565 p.

    Research output: Contribution to journalArticle

  14. 2015
  15. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: Evidence for increased levels of serum bactericidal antibodies.

    Brodszki, N., Lillemor Melander Skattum, Bai, X., Findlow, H., Borrow, R. & Jönsson, G., 2015, In : Vaccine. 33, 15, p. 1839-1845

    Research output: Contribution to journalArticle

  16. 2014
  17. Seasonal influenza vaccine effectiveness against influenza in 2012-2013: A hospital-based case-control study in Lithuania

    Giedre Gefenaite, Rahamat-Langendoen, J., Ambrozaitis, A., Mickiene, A., Jancoriene, L., Kuliese, M., Velyvyte, D., Niesters, H., Stolk, R. P., Zagminas, K. & Hak, E., 2014 Feb 7, In : Vaccine. 32, 7, p. 857-863

    Research output: Contribution to journalArticle

  18. Parental attitudes and decision-making regarding MMR vaccination in an anthroposophic community in Sweden - A qualitative study.

    Byström, E., Lindstrand, A., Likhite, N., Butler, R. & Maria Emmelin, 2014, In : Vaccine. 32, 50, p. 6752-6757

    Research output: Contribution to journalArticle

  19. 2013
  20. 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial

    Silfverdal, S. A., Flodmark, C-E., Rombo, L., Tansey, S. P., Sidhu, M., Trammel, J., Emini, E. A., Gruber, W. C., Scott, D. A. & Gurtman, A., 2013, In : Vaccine. 31, 9, p. 1284-1292

    Research output: Contribution to journalArticle

  21. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program

    Ucakar, V., Jelen, M. M., Faust, H., Poljak, M., Dillner, J. & Klavs, I., 2013, In : Vaccine. 31, 43, p. 4935-4939

    Research output: Contribution to journalArticle

  22. The immunological effect of revaccination with Bacille Calmette-Guerin vaccine at 19 months of age

    Andersen, A., Adam Roth, Jensen, K. J., Erikstrup, C., Lisse, I. M., Whittle, H., Sartono, E., Yazdanbakhsh, M., Aaby, P. & Benn, C. S., 2013, In : Vaccine. 31, 17, p. 2137-2144

    Research output: Contribution to journalArticle

  23. 2012
  24. A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix (R) in subjects aged 11-17 years: An open, randomised, controlled trial

    Ostergaard, L., Silfverdal, S-A., Berglund, J., Flodmark, C-E., West, C., Bianco, V., Baine, Y. & Miller, J. M., 2012, In : Vaccine. 30, 4, p. 774-783

    Research output: Contribution to journalArticle

  25. International collaborative proficiency study of Human Papillomavirus type 16 serology.

    Eklund, C., Unger, E. R., Nardelli-Haefliger, D., Zhou, T. & Dillner, J., 2012, In : Vaccine. 30, p. 294-299

    Research output: Contribution to journalArticle

  26. 2011
  27. Effectiveness of the Q fever vaccine: A meta-analysis

    G. Gefenaite, Munster, J. M., van Houdt, R. & Hak, E., 2011 Jan 10, In : Vaccine. 29, 3, p. 395-398

    Research output: Contribution to journalReview article

  28. Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.

    Okroj, M., Tedeschi, R., Mancuso, R., Brambilla, L., Tourlaki, A., Dillner, J. & Anna Blom, 2011, In : Vaccine. 29, p. 1129-1134

    Research output: Contribution to journalArticle

  29. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants

    Verhaegh, S. J. C., de Vogel, C. P., Kristian Riesbeck, Lafontaine, E. R., Murphy, T. F., Verbrugh, H. A., Jaddoe, V. W. V., Hofman, A., Moll, H. A., van Belkum, A. & Hays, J. P., 2011, In : Vaccine. 29, 34, p. 5603-5610

    Research output: Contribution to journalArticle

  30. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis

    Ricci, S., Janulczyk, R., Gerlini, A., Braione, V., Colomba, L., Iannelli, F., Chiavolini, D., Oggioni, M. R., Lars Björck & Pozzi, G., 2011, In : Vaccine. 29, 46, p. 8241-8249

    Research output: Contribution to journalArticle

  31. 2010
  32. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice

    Shanice Yc Su, Wan, K-L. & Nathan, S., 2010 Jul 12, In : Vaccine. 28, 31, p. 5005-5011

    Research output: Contribution to journalArticle

  33. Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy.

    Broos, S., Kristina Lundberg, Akagi, T., Kadowaki, K., Akashi, M., Greiff, L., Carl Borrebaeck & Malin Lindstedt, 2010, In : Vaccine. 28, p. 5075-5085

    Research output: Contribution to journalArticle

  34. Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC)

    Stefanoff, P., Mamelund, S-E., Robinson, M., Eva Netterlid, Tuells, J., Bergsaker, M. A. R., Heijbel, H. & Yarwood, J., 2010, In : Vaccine. 28, 35, p. 5731-5737

    Research output: Contribution to journalArticle

  35. 2009
  36. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells

    Hinkula, J., Walther-Jallow, L., Laurén, A., Makitalo, B., Öberg, M., Wahren, B., Eva Maria Fenyö & Spetz, A-L., 2009, In : Vaccine. 27, 46, p. 6424-6431

    Research output: Contribution to journalArticle

  37. Prevention of otitis media: Now a reality?

    Schuerman, L., Borys, D., Hoet, B., Forsgren, A. & Prymula, R., 2009, In : Vaccine. 27, 42, p. 5748-5754

    Research output: Contribution to journalReview article

  38. Risk of lymphoma and leukaemia after bacille Calmette-Guerin and smallpox vaccination: A Danish case-cohort study

    Villumsen, M., Sorup, S., Jess, T., Ravn, H., Relander, T., Baker, J. L., Benn, C. S., Sorensen, T. I. A., Aaby, P. & Adam Roth, 2009, In : Vaccine. 27, 49, p. 6950-6958

    Research output: Contribution to journalArticle

  39. Surveillance of Vaccine Safety: Comparison of parental reports with routine surveillance and a clinical trial

    Eva Netterlid, Edwinson Månsson, M. & Håkansson, A., 2009, In : Vaccine. 27, 14, p. 2042-2047

    Research output: Contribution to journalArticle

  40. 2008
  41. Sampling for low-pathogenic avian influenza A virus in wild Mallard ducks: Oropharyngeal versus cloacal swabbing

    Ellström, P., Latorre-Margalef, N., Griekspoor, P., Waldenström, J., Olofsson, J., Wahlgren, J. & Olsen, B., 2008 Aug 18, In : Vaccine. 26, 35, p. 4414-4416 3 p.

    Research output: Contribution to journalLetter

  42. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden

    Spindler, C., Hedlund, J., Jasir, A., Normark, B. H. & Ortqvist, A., 2008, In : Vaccine. 26, 43, p. 5541-5546

    Research output: Contribution to journalArticle

  43. Global HIV Vaccine Research Cryorepository - GHRC

    von Briesen, H., Eva Maria Fenyö, Holmes, H., Karamov, E. V., Meyerhans, A. & Morgado, M., 2008, In : Vaccine.

    Research output: Contribution to journalPublished meeting abstract

  44. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

    Joura, E. A., Kjaer, S. K., Wheeler, C. M., Sigurdsson, K., Iversene, O-E., Hernandez-Avila, M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., Garcia, P., Ault, K. A., Garland, S. M., Leodolter, S., Olssonn, S-E., Tang, G. W. K., Ferris, D. G., Paavonen, J., Lehtinen, M., Steben, M. & 18 others, Bosch, X., Dillner, J., Kurmanv, R. J., Majewski, S., Munoz, N., Myers, E. R., Villa, L. L., Taddeo, F. J., Roberts, C., Tadesse, A., Bryan, J., Lupinaccia, L. C., Giacoletti, K. E. D., Lu, S., Vuocolo, S., Hesley, T. M., Haupt, R. M. & Barr, E., 2008, In : Vaccine. 26, 52, p. 6844-6851

    Research output: Contribution to journalArticle

  45. Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

    Cuzick, J., Arbyn, M., Sankaranarayanan, R., Tsu, V., Ronco, G., Mayrand, M-H., Dillner, J. & Meijer, C. J. L. M., 2008, In : Vaccine. 26, p. K29-K41

    Research output: Contribution to journalArticle

  46. Seroepidemiology as basis for design of a human papillomavirus vaccination program.

    Ryding, J., French, K. M., Naucler, P., Barnabas, R. V., Garnett, G. P. & Dillner, J., 2008, In : Vaccine. Aug 8, p. 5263-5268

    Research output: Contribution to journalArticle

  47. Species-specificity of Neisseria gonorrhoeae infection: Do human complement regulators contribute?

    Ngampasutadol, J., Tran, C., Gulati, S., Anna Blom, Jerse, A. E., Ram, S. & Rice, P. A., 2008, In : Vaccine. 26, p. I62-I66

    Research output: Contribution to journalArticle

  48. 2007
  49. The benefit of molecular characterization during a measles upsurge in Denmark

    Muscat, M., Vinner, L., Christiansen, A. H., Glismann, S. & Blenda Elisabeth Böttiger, 2007 Aug 14, In : Vaccine. 25, 33, p. 6232-6

    Research output: Contribution to journalArticle

  50. A non-beneficial effect of BCG on non-tuberculous childhood mortality?

    Adam Roth & Nielsen, J., 2007, In : Vaccine. 25, 1, p. 12-13

    Research output: Contribution to journalLetter

  51. Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals

    Okroj, M., Spiller, O. B., Korodi, Z., Tedeschi, R., Dillner, J. & Anna Blom, 2007, In : Vaccine. 25, 48, p. 8102-8109

    Research output: Contribution to journalArticle

  52. Children exposed to environmental smoking have a higher antibiotic consumption.

    Percy Nilsson Wimar, Köhler, M., Per-Olof Östergren & Khan, F., 2007, In : Vaccine. 25, 13, p. 2533-2535

    Research output: Contribution to journalArticle

  53. Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection.

    Adam Linder, Hollingshead, S., Janulczyk, R., Bertil Christensson & Per Åkesson, 2007, In : Vaccine. 25, 2, p. 341-345

    Research output: Contribution to journalArticle

  54. Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines.

    Carlsson, F., Adler, SP., Lamarre, A. & Mats Ohlin, 2007, In : Vaccine. 26, 1, p. 41-46

    Research output: Contribution to journalArticle

  55. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    Olsson, S-E., Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Malm, C., Iversen, O-E., Hoye, J., Steinwall, M., Riis-Johannessen, G., Andersson-Ellstrom, A., Elfgren, K., von Krogh, G., Lehtinen, M., Paavonen, J., Tamms, G. M., Giacoletti, K., Lupinacci, L., Esser, M. T., Vuocolo, S. C. & 2 others, Saah, A. J. & Barr, E., 2007, In : Vaccine. 25, 26, p. 4931-4939

    Research output: Contribution to journalArticle

  56. 2006
  57. Clinical applications of HPV testing: A summary of meta-analyses

    Arbyn, M., Sasieni, P., Meijer, C. J. L. M., Clavel, C., Koliopoulos, G. & Dillner, J., 2006, In : Vaccine. 24, Suppl. 3, p. 78-89

    Research output: Contribution to journalArticle

  58. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Villa, L. L., Ault, K. A., Giuliano, A. R., Costa, R. L. R., Petta, C. A., Andrade, R. P., Brown, D. R., Ferenczy, A., Harper, D. M., Koutsky, L. A., Kurman, R. J., Lehtinen, M., Malm, C., Olsson, S-E., Ronnett, B. M., Skjeldestad, F. E., Steinwall, M., Stoler, M. H., Wheeler, C. M., Taddeo, F. J. & 11 others, Yu, J., Lupinacci, L., Railkar, R., Marchese, R., Esser, M. T., Bryan, J., Jansen, K. U., Sings, H. L., Tamms, G. M., Saah, A. J. & Barr, E., 2006, In : Vaccine. 24, 27-28, p. 5571-5583

    Research output: Contribution to journalArticle

  59. International Standard reagents for harmonization of HPV serology and DNA assays - an update

    Pagliusi, S. R., Dillner, J., Pawlita, M., Quint, W. G. V., Wheeler, C. M. & Ferguson, M., 2006, In : Vaccine. 24, Suppl. 3, p. 193-200

    Research output: Contribution to journalArticle

Previous 1 2 Next